Is Augmentin (amoxicillin/clavulanate) safe to use during breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin (Amoxicillin/Clavulanate) and Breastfeeding

Augmentin is safe and compatible with breastfeeding—it is explicitly recommended by the American Academy of Dermatology and classified as the highest safety designation ("compatible") by the European Respiratory Society guidelines. 1, 2

Safety Classification

  • Augmentin receives the highest safety designation for antibiotics during lactation, classified as "compatible" with breastfeeding by the European Respiratory Society/Thoracic Society of Australia and New Zealand (ERS/TSANZ) guidelines. 1
  • The American Academy of Dermatology specifically recommends amoxicillin/clavulanic acid as a safe and effective choice during breastfeeding, with FDA Category B classification. 1, 2
  • The FDA drug label confirms that amoxicillin is excreted in human milk, though it advises caution should be exercised when administered to nursing women. 3

Clinical Evidence and Rationale

  • Penicillins and aminopenicillins, including amoxicillin, are present in breast milk at low concentrations, making the infant exposure minimal. 1
  • The European Respiratory Society guidelines explicitly state that breastfeeding should not be interrupted when amoxicillin is prescribed, as the benefits of continued breastfeeding outweigh the minimal risks of exposure through breast milk. 1
  • Research confirms that most commonly used drugs, including antibiotics like Augmentin, are relatively safe for breastfed babies, with the dose received via milk being generally small and much less than known safe doses given directly to infants. 4

Infant Monitoring Recommendations

  • Monitor all breastfed infants for mild gastrointestinal effects (diarrhea, gastroenteritis) due to potential alteration of intestinal flora, though serious adverse events are rare. 1, 2
  • Be aware that antibiotics in breast milk could potentially cause falsely negative cultures if the breastfed infant develops a fever requiring evaluation. 1
  • Watch for potential sensitization of infants, as noted in the FDA label, though this is uncommon. 3

Important Caveat to Avoid

  • Do not confuse the pregnancy precaution with breastfeeding safety: Amoxicillin/clavulanic acid should not be used in women at risk of pre-term delivery due to a very low risk of necrotizing enterocolitis in the fetus. 1
  • However, this caveat applies only to pregnancy/delivery contexts, not to postpartum breastfeeding in term infants—co-amoxiclav remains fully compatible and safe for breastfeeding mothers after term delivery. 1

Prescribing Guidance

  • Use the lowest effective dose for the shortest duration needed when prescribing Augmentin to breastfeeding mothers. 2
  • Standard adult dosing is 250 mg twice daily up to 500 mg three times daily, or the common formulation of 875 mg/125 mg every 12 hours. 1
  • If Augmentin is not suitable, safe alternatives include erythromycin or azithromycin (though azithromycin should ideally be avoided during the first 13 days postpartum). 1, 2

References

Guideline

Safety of Antibiotics During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safety of Augmentin During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drugs in breastfeeding.

Australian prescriber, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.